3rd Quarter Report of 2023
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
View Attachment
3rd Quarter Report of 2023
Filed with SSE ·
3rd Quarter Report of 2023
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
View Attachment
6ix hasn’t read this filing yet.
Shanghai Serum Bio-Technology Co., Ltd. on 6ix
Earlier from Shanghai Serum Bio-Technology
- Announcement on Expiry of Term of Office of Independent Directors and Postponement of Election of Independent Directors
- Announcement on Convening 2023 Semi-annual Performance Meeting
- Announcement on Circulation of Some Restricted Shares in Initial Public Offering
- Announcement on Resolutions of 11th Session of 3rd Board of Supervisors
Later from Shanghai Serum Bio-Technology
- Announcement on Releasing Detention of One of Actual Controllers and Chairman
- Announcement on Convening 2023 3rd Quarter Performance Meeting
- Announcement on Resolutions of 17th Session of 3rd Board of Directors
- Announcement on Resolutions of 1st Special Shareholders' Meeting of 2023
- Announcement on Voluntary Disclosure of Ethical Review Approval for Phase II Clinical Trial of Antivenom Serum against Viper Venom
Follow Shanghai Serum Bio-Technology into a list and get an email when it puts out news.
Follow Shanghai Serum Bio-Technology